GM vs F vs RIVN
161 measures in 16 categories, one definition each, computed from filings and market data.
GM27.2
General Motors Company
Consumer Cyclical · Auto - Manufacturers
$83.96 +0.36%$73.7B mkt cap
Score DNA
F11.8
Ford Motor Company
Consumer Cyclical · Auto - Manufacturers
$12.43 +0.97%$49.6B mkt cap
Score DNA
RIVN27.4
Rivian Automotive, Inc.
Consumer Cyclical · Auto - Manufacturers
$12.42 −4.61%$17.9B mkt cap
Score DNA
Price, rebased to 100 three years ago
GM F RIVN · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | GM | F | RIVN |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 1 | 2 |
| Insider $ bought, 180d | — | $0.15M | $1,000.19M |
| Congress purchases, 180d | 1 | 1 | 0 |
| Last Congress purchase | 2026-03-27 | 2026-08-10 | — |
| 13F net change in holders | +52 | +37 | +18 |
| ETFs adding shares, 30d | 1,104 | 1,043 | 736 |
| ETFs trimming, 30d | 987 | 904 | 522 |
| Net ETF funds, 30d | +117 | +139 | +214 |
Valuation
16 measures| Measure | GM | F | RIVN |
|---|---|---|---|
| P/E (TTM) | 38.4x | — | — |
| PEG (P/E ÷ 3-yr EPS CAGR) | — | — | — |
| Price / sales | 0.4x
25th
|
0.3x
12th
|
3.0x
88th
|
| Price / book | 1.2x
33rd
|
1.4x
50th
|
3.5x
83rd
|
| Price / tangible book | 1.2x
17th
|
1.6x
50th
|
4.4x
67th
|
| Price / free cash flow | 4.5x | 6.8x | — |
| Price / operating cash flow | 3.2x | 2.9x | — |
| Enterprise value | $176.6B
75th
|
$181.5B
88th
|
$18.0B
62nd
|
| EV / sales | 1.0x
12th
|
1.0x
25th
|
3.1x
88th
|
| EV / EBITDA | 11.8x | — | — |
| EV / EBIT | 91.5x | — | — |
| EV / free cash flow | 10.7x | 24.9x | — |
| Earnings yield | 2.6%
75th
|
-14.9%
50th
|
-18.0%
38th
|
| FCF yield | 22.4%
100th
|
14.7%
86th
|
-19.5%
29th
|
| Operating cash flow yield | 31.5%
86th
|
34.2%
100th
|
-10.3%
29th
|
| Graham number (per share) | $56.26 | — | — |
Profitability (TTM)
12 measures| Measure | GM | F | RIVN |
|---|---|---|---|
| Gross margin | 5.7%
25th
|
10.8%
62nd
|
7.5%
38th
|
| EBITDA margin | 8.1%
88th
|
-0.9%
50th
|
-36.6%
25th
|
| Operating margin | 1.0%
50th
|
1.9%
62nd
|
-60.1%
38th
|
| EBIT margin | 1.0%
62nd
|
-4.4%
50th
|
-50.3%
25th
|
| Net margin | 1.0%
62nd
|
-3.9%
50th
|
-55.0%
38th
|
| NOPAT margin | 1.0%
50th
|
1.5%
62nd
|
-47.4%
38th
|
| FCF margin | 8.9%
88th
|
3.9%
62nd
|
-59.3%
25th
|
| Operating cash flow margin | 12.5%
88th
|
9.0%
62nd
|
-31.4%
38th
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
30.3%
88th
|
| SG&A / revenue | 4.8%
0th
|
5.8%
12th
|
33.9%
75th
|
| Stock comp / revenue | 0.0%
0th
|
0.2%
29th
|
13.5%
86th
|
| Effective tax rate | -0.2%
0th
|
21.0%
25th
|
21.0%
25th
|
Returns on capital
11 measures| Measure | GM | F | RIVN |
|---|---|---|---|
| ROE (on average equity) | 3.0%
50th
|
-18.3%
33rd
|
-57.8%
17th
|
| ROA | 0.7%
62nd
|
-2.6%
50th
|
-21.0%
38th
|
| ROIC | 1.1%
38th
|
1.7%
50th
|
-54.0%
25th
|
| ROCE | 1.0%
38th
|
-4.7%
25th
|
-25.7%
12th
|
| Return on tangible assets | 0.7%
62nd
|
-2.9%
50th
|
-19.2%
38th
|
| Cash ROIC (OCF / invested capital) | 14.1%
71st
|
10.1%
57th
|
-35.7%
29th
|
| Gross profitability (GP / assets) | 3.8%
50th
|
7.0%
62nd
|
2.4%
38th
|
| ROIC, 3-yr average | 3.6%
57th
|
1.7%
43rd
|
-53.2%
29th
|
| ROIC, 5-yr average | 4.6%
50th
|
3.1%
33rd
|
-54.6%
17th
|
| ROE, 5-yr average | 10.9%
67th
|
6.2%
50th
|
-58.2%
17th
|
| Incremental ROIC | 23.9%
100th
|
-5.9%
17th
|
1.2%
50th
|
Growth
17 measures| Measure | GM | F | RIVN |
|---|---|---|---|
| Revenue growth (TTM YoY) | -1.1%
14th
|
1.5%
29th
|
14.2%
71st
|
| Revenue growth (QoQ) | 10.1%
38th
|
11.7%
50th
|
20.1%
62nd
|
| Revenue CAGR, 3 yr | 3.0%
14th
|
3.4%
43rd
|
25.4%
86th
|
| Revenue CAGR, 5 yr | 5.8%
20th
|
6.6%
40th
|
— |
| Gross profit CAGR, 3 yr | -21.9%
25th
|
5.0%
75th
|
— |
| Operating income CAGR, 3 yr | -45.8% | -18.3% | — |
| Net income growth (TTM YoY) | -59.8% | — | — |
| Net income CAGR, 3 yr | -42.8% | — | — |
| EPS growth (TTM YoY) | -57.4% | — | — |
| EPS CAGR, 3 yr | -34.4% | — | — |
| EPS CAGR, 5 yr | -24.8% | — | — |
| FCF growth (TTM YoY) | — | -28.1% | — |
| FCF CAGR, 3 yr | — | 11.2% | — |
| Operating cash flow CAGR, 3 yr | 2.6% | 9.7% | — |
| Book value CAGR, 3 yr | 9.3%
50th
|
-6.1%
33rd
|
-31.6%
17th
|
| Dividend CAGR, 3 yr | 40.4% | -6.6% | — |
| Sustainable growth rate | 1.2% | — | — |
Margin history & stability
7 measures| Measure | GM | F | RIVN |
|---|---|---|---|
| Gross margin, 3-yr average | 9.5%
57th
|
8.6%
43rd
|
-13.1%
29th
|
| Operating margin, 3-yr average | 4.4%
57th
|
1.9%
43rd
|
-82.4%
14th
|
| Net margin, 3-yr average | 3.3%
57th
|
-0.0%
43rd
|
-79.5%
14th
|
| FCF margin, 3-yr average | 1.4%
43rd
|
4.1%
57th
|
-61.1%
29th
|
| Revenue stability (0-1) | 0.90
71st
|
0.91
86th
|
0.84
43rd
|
| Earnings stability (0-1) | 0.72
43rd
|
0.49
29th
|
0.77
86th
|
| Margin stability (0-1) | 0.69
57th
|
0.83
86th
|
0.00
0th
|
Liquidity (latest quarter)
7 measures| Measure | GM | F | RIVN |
|---|---|---|---|
| Cash & short-term investments | $24.7B
75th
|
$31.3B
88th
|
$5.3B
62nd
|
| Net cash (− = net debt) | −$103.0B
12th
|
−$132.0B
0th
|
−$43.0M
75th
|
| Working capital | $13.2B
88th
|
$9.6B
75th
|
$4.0B
62nd
|
| Current ratio | 1.14
38th
|
1.09
25th
|
2.10
100th
|
| Quick ratio | 0.97
62nd
|
0.93
50th
|
1.65
88th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.26
25th
|
0.29
38th
|
1.47
100th
|
| Defensive interval (days) | 1,715 days
75th
|
2,106 days
100th
|
532 days
50th
|
Leverage & solvency (latest quarter)
13 measures| Measure | GM | F | RIVN |
|---|---|---|---|
| Total debt | $127.7B
88th
|
$163.3B
100th
|
$5.4B
50th
|
| Debt / equity | 2.06
83rd
|
4.57
100th
|
1.04
50th
|
| Net debt / equity | 1.66
83rd
|
3.69
100th
|
0.01
33rd
|
| Debt / assets | 45.2%
62nd
|
57.2%
88th
|
35.4%
38th
|
| Debt / capital | 67.3%
83rd
|
82.1%
100th
|
51.1%
50th
|
| Debt / EBITDA | 8.53 | — | — |
| Net debt / EBITDA | 6.88 | — | — |
| Interest coverage (EBIT / interest) | 2.8x
62nd
|
−6.0x
50th
|
−11.1x
25th
|
| Cash interest coverage | 33.5x
88th
|
12.2x
62nd
|
−6.9x
38th
|
| Debt payback (years of OCF) | 5.5 yrs | 9.6 yrs | — |
| Liabilities / assets | 77.5%
62nd
|
87.5%
75th
|
66.1%
38th
|
| IS credit model rating | B+ | B- | B |
| Implied credit spread (bps) | 650
38th
|
900
62nd
|
750
50th
|
Efficiency
11 measures| Measure | GM | F | RIVN |
|---|---|---|---|
| Asset turnover | 0.65
50th
|
0.65
62nd
|
0.38
12th
|
| Fixed asset turnover | 2.15
50th
|
2.71
62nd
|
0.94
12th
|
| Inventory turnover | 11.1
100th
|
9.8
88th
|
2.9
12th
|
| Receivables turnover | 4.8
38th
|
3.3
12th
|
18.9
75th
|
| Days sales outstanding | 77 days
62nd
|
109 days
88th
|
19 days
25th
|
| Days inventory outstanding | 33 days
0th
|
37 days
12th
|
124 days
88th
|
| Days payables outstanding | 58 days
50th
|
60 days
62nd
|
46 days
25th
|
| Cash conversion cycle (days) | 51 days
50th
|
87 days
62nd
|
98 days
75th
|
| Capex / revenue | 3.6%
25th
|
5.1%
38th
|
27.9%
88th
|
| Capex / depreciation | 0.51
0th
|
1.49
38th
|
2.05
62nd
|
| Operating expense ratio | 4.6%
0th
|
11.3%
25th
|
61.2%
88th
|
Cash flow & earnings quality
7 measures| Measure | GM | F | RIVN |
|---|---|---|---|
| Operating cash flow / net income | 12.10 | — | — |
| FCF / net income | 8.60 | — | — |
| FCF / operating cash flow | 71.1% | 43.0% | — |
| Capex / operating cash flow | 28.9% | 57.0% | — |
| Accruals ratio | -7.4%
50th
|
-8.4%
38th
|
-9.0%
25th
|
| Sloan accruals ratio | -7.1%
50th
|
-3.0%
75th
|
-25.9%
38th
|
| Earnings quality score (0-1) | 0.75 | — | — |
Scores & forensic checks
15 measures| Measure | GM | F | RIVN |
|---|---|---|---|
| IS score | 27
62nd
|
12
0th
|
27
75th
|
| IS profitability | 9
62nd
|
5
50th
|
3
38th
|
| IS growth | 19
0th
|
34
43rd
|
67
86th
|
| IS value | 56
75th
|
40
50th
|
36
38th
|
| IS momentum | 54
57th
|
36
14th
|
63
86th
|
| IS risk (safety) | 15
50th
|
15
50th
|
0
0th
|
| IS quality | 51
75th
|
21
0th
|
41
62nd
|
| IS balance sheet | 30
50th
|
25
38th
|
42
62nd
|
| IS earnings quality | 76
100th
|
41
38th
|
58
75th
|
| IS cash flow | 54
88th
|
24
12th
|
30
25th
|
| Piotroski F-score (0-9) | 6
88th
|
4
38th
|
5
50th
|
| Altman Z-score | 1.2
62nd
|
0.8
50th
|
−1.2
38th
|
| Beneish M-score | −3.40
0th
|
−3.19
29th
|
−3.29
14th
|
| Ohlson O-score | −7.37
38th
|
−6.30
50th
|
−6.11
62nd
|
| IS credit score | 32
62nd
|
23
38th
|
28
50th
|
Size (TTM)
8 measures| Measure | GM | F | RIVN |
|---|---|---|---|
| Market cap | $73.7B
88th
|
$49.6B
75th
|
$17.9B
62nd
|
| Revenue | $185.5B
88th
|
$188.0B
100th
|
$5.9B
62nd
|
| EBITDA | $15.0B
100th
|
−$1.8B
25th
|
−$2.2B
12th
|
| Net income | $1.9B
88th
|
−$7.4B
0th
|
−$3.2B
25th
|
| Free cash flow | $16.5B
100th
|
$7.3B
88th
|
−$3.5B
12th
|
| Total assets | $282.7B
88th
|
$285.5B
100th
|
$15.1B
62nd
|
| Shareholders' equity | $62.0B
88th
|
$35.7B
75th
|
$5.1B
62nd
|
| Employees | 156,000
88th
|
169,000
100th
|
15,232
62nd
|
Price performance
9 measures| Measure | GM | F | RIVN |
|---|---|---|---|
| 1 day | +0.4% | +1.0% | −4.6% |
| 1 week | +1.5% | +2.1% | −11.0% |
| 1 month | −3.1% | −8.7% | −19.4% |
| 3 months | +10.8% | −10.2% | −28.0% |
| 6 months | +3.2% | −1.2% | −27.9% |
| Year to date | +3.7% | −3.6% | −36.0% |
| 1 year | +45.6% | +10.6% | −7.4% |
| 3 years, cumulative | +177.5% | +22.3% | −35.9% |
| 5 years, cumulative | +48.5% | +11.9% | — |
Technicals
4 measures| Measure | GM | F | RIVN |
|---|---|---|---|
| RSI 14 | 53.5 | 45.2 | 23.1 |
| From 52-week high | −8.6% | −29.4% | −45.3% |
| From 52-week low | +48.1% | +14.5% | +0.5% |
| Beta | 1.40 | 1.94 | 1.62 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17